Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real® by providing high-quality nonclinical, clinical and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing -- We have supported the development of each of the top 50 prescription drugs in the marketplace today. We are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase I-IV clinical trial and commercialization services. Together with our clients, we create solutions that transform potential into reality.
Mobile Health Solutions: Realize the Promise and Potential of Mobile Health
Patients and clinicians are engaging with technology in ways that can fundamentally change the quantity and richness of your clinical trial data. You can harness the power of mobile health in your clinical trial with a partner who provides expert clinical and regulatory guidance and thoughtfully designed mobile health application and device validation services. Our solutions that can transform your trial data include a vibrant network of regulatory affairs experts and specialty partners to guide you to a successful submission. Reliable, consistent, repeatable and scalable data are delivered by our experts specializing in validation, design and execution.
Your outcomes are optimized by our trial capabilities, device and application validation expertise and analytic support. Learn more about how to apply the potential of mobile health in your trial with an expert partner.
Visit http://www.covance.com/mhealth for more information.
210 Carnegie Center
Princeton, NJ 08540
Mobile health momentum is building as new technologies emerge. The first steps in your journey — including regulatory strategy and device/data validation —can be challenging.
To enter the rapidly growing mobile health space, companies must overcome the Mobile Health Development-crucial hurdle of validation. This process demonstrates that the app – in combination with the underlying technology platform / device – performs comparably to traditional products on the market, ensuring that patients and providers can rely on the output to make appropriate medical decisions.
Mobile health applications have the potential to significantly change drug development, clinical trials and the administration of health care.
For many technology companies entering the mobile health space, meeting US Food and Drug Administration (FDA) requirements may be unfamiliar territory. The guidelines can appear convoluted and contradictory at first glance, and some devices and/or applications (apps) fall into regulatory grey areas.